| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/03/1997 | WO1997023508A1 Compounds with growth hormone releasing properties |
| 07/03/1997 | WO1997023485A1 Heteroarylcarboxamide derivatives |
| 07/03/1997 | WO1997023204A1 Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes |
| 07/03/1997 | WO1997023203A1 Aminoguanidine for treating niddm |
| 07/03/1997 | WO1997023200A1 Pharmaceutical composition stabilized with a basic agent |
| 07/03/1997 | WO1997016185A3 A pharmaceutical composition for the treatment of autoimmune diseases |
| 07/03/1997 | CA2240492A1 Aminoguanidine for treating niddm |
| 07/03/1997 | CA2240396A1 Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes |
| 07/03/1997 | CA2239711A1 Compounds with growth hormone releasing properties |
| 07/03/1997 | CA2238873A1 Cell activation process and reagents therefor |
| 07/02/1997 | EP0781756A1 Soluble concentrated frozen/refrigerated calcium preparation comprising calcium citrate malate and process for producing the same |
| 07/02/1997 | EP0781550A1 Bioadhesive pharmaceutical composition for the controlled release of active agents |
| 07/02/1997 | EP0781326A1 The irs family of genes |
| 07/02/1997 | EP0781282A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE |
| 07/02/1997 | EP0781278A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 07/02/1997 | EP0781129A1 Pharmaceutical preparation containing metformin and a process for producing it |
| 07/02/1997 | EP0703911B1 Secondary amines as antidiabetic and antiobesity agents |
| 07/02/1997 | CN1153473A Use of droloxifene for treatment of cardiovascular diseases |
| 07/01/1997 | US5643936 Treatment of angiogenic conditions and anticarcinogenic agents |
| 07/01/1997 | US5643932 Superoxide radical inhibitor |
| 07/01/1997 | US5643931 Bisoxadiazolidine derivative |
| 07/01/1997 | US5643921 Cardiopulmonary bypass and organ transplant using a potassium channel activator |
| 07/01/1997 | US5643896 2-Benzyl-3-arylbenzothiophenes |
| 07/01/1997 | US5643874 Pharmaceutical composition comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor |
| 07/01/1997 | US5643868 Method of treating or preventing type 1 diabetes by oral administration of insulin |
| 07/01/1997 | US5643584 Aqueous gel retinoid dosage form |
| 07/01/1997 | US5643569 Preparation of agarose coated, solid agarose-collagen beads containing secretory cells |
| 07/01/1997 | CA2134359C New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
| 07/01/1997 | CA2012381C Reduced calorie fat compositions containing polyol polyesters and reduced calorie triglycerides |
| 06/29/1997 | CA2188247A1 Soluble concentrated frozen/refrigerated calcium preparation comprising calcium citrate-malate and process for producing the same |
| 06/26/1997 | WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/26/1997 | WO1997022600A1 N-substituted dioxothiazolidylbenzamide derivatives and process for producing the same |
| 06/26/1997 | WO1997022360A2 Control of protein synthesis, and screening method for agents |
| 06/26/1997 | WO1997022338A1 Novel method |
| 06/26/1997 | CA2241080A1 Control of protein synthesis, and screening method for agents |
| 06/26/1997 | CA2240489A1 Inhibitors of interleukin-1.beta. converting enzyme |
| 06/26/1997 | CA2239487A1 Novel method |
| 06/25/1997 | EP0780389A1 Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them |
| 06/25/1997 | EP0780388A1 5HT1Dalpha and 5HT2A ligands |
| 06/25/1997 | EP0780387A1 Thiophene compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/25/1997 | EP0780386A1 Matrix metalloprotease inhibitors |
| 06/25/1997 | EP0780128A2 Crotonic acid amide derivatives and lipoprotein containing compositions |
| 06/25/1997 | EP0780124A1 Pharmaceutical composition comprising L-carnitine or an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders |
| 06/25/1997 | EP0780123A1 Beta-hydroxybutyric acid or acetoacetic acid or salts or esters therof for use in improving cerebral function |
| 06/25/1997 | EP0780055A2 Nutritional coffee composition |
| 06/25/1997 | EP0779813A1 Phosphonates and parathyroid hormone for osteoporosis |
| 06/25/1997 | EP0779812A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
| 06/25/1997 | EP0779810A1 Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes |
| 06/25/1997 | CN1152868A Use of droloxidfene for the treatment of cardiovascular diseases |
| 06/25/1997 | CN1152867A Methods and compositions for pulmonary delivery of insulin |
| 06/25/1997 | CN1035256C Process for preparation of new polypetide compound |
| 06/24/1997 | US5641796 Oral hypoglycemic agents |
| 06/24/1997 | US5641790 Pharmaceutical formulation in low dosage unit form containing 2-phenyl-3-aroylbenzothiophene derivative |
| 06/24/1997 | US5641767 Modified bile acids process for their preparation and their use |
| 06/24/1997 | US5641756 Synthetic oligonucleotide complementary to nucleic acid specific for human vascular endothelial growth factor |
| 06/24/1997 | US5641752 Methods of using endothelin antagonists |
| 06/24/1997 | US5641744 Treatment of diabetes mellitus |
| 06/24/1997 | US5641657 DNA encoding an interleukin-6 splice variant |
| 06/24/1997 | CA2010054C Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin |
| 06/23/1997 | CA2193171A1 Thiazolidinedione derivatives, method for preparing the derivatives and pharmaceutical compositions containing same |
| 06/22/1997 | CA2193308A1 New thiophene compounds; process for preparing the same and pharmaceutical compositions containing them |
| 06/19/1997 | WO1997021993A2 Nuclear receptor ligands and ligand binding domains |
| 06/19/1997 | WO1997021690A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 06/19/1997 | WO1997021676A1 Azetidinone compounds for the treatment of atherosclerosis |
| 06/19/1997 | WO1997021675A1 Monocyclic beta-lactame derivatives for treatment of atherosclerosis |
| 06/19/1997 | WO1997021665A1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors |
| 06/19/1997 | WO1996040098A3 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 06/19/1997 | CA2240024A1 Nuclear receptor ligands and ligand binding domains |
| 06/19/1997 | CA2238175A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 06/18/1997 | EP0779291A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/18/1997 | EP0779279A1 Bicyclic heterocycles |
| 06/18/1997 | EP0779276A1 Indolyl-substituted phenylacetic acid derivatives |
| 06/18/1997 | EP0779076A1 Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 06/18/1997 | EP0778778A1 Probiotic compositions |
| 06/18/1997 | EP0778767A2 Delivery of solid drug compositions |
| 06/18/1997 | EP0662953B1 Novel vitamin d analogues |
| 06/18/1997 | CN1152312A New azolidinediones as antihyperglycemic agents |
| 06/18/1997 | CN1152302A Retinoic acid X-receptor ligands |
| 06/18/1997 | CN1152258A Method and composition for increasing calcium uptake |
| 06/18/1997 | CN1152254A Therapeutic food composition and method to diminish blood sugar fluctuations |
| 06/18/1997 | CN1151888A Medicine for diabetes and its prepn |
| 06/18/1997 | CN1035177C Prep. of 20-methyl-substituted vitamin D-derivatives |
| 06/17/1997 | US5639783 Ketone derivatives |
| 06/17/1997 | US5639781 Alcohol or aldehyde derivatives and their use |
| 06/17/1997 | US5639779 Treatment of different types of headaches |
| 06/17/1997 | US5639756 Antidiabetic agents |
| 06/17/1997 | US5639752 Serotonin agonist |
| 06/17/1997 | US5639275 Capsule containing genetically engineered cells |
| 06/12/1997 | WO1997020811A1 Vitamin d analogues |
| 06/12/1997 | WO1997020569A2 Bioartificial devices and cellular matrices therefor |
| 06/12/1997 | WO1997012963A3 A paf-acetylhydrolase and use in therapy |
| 06/12/1997 | WO1997004668A3 Two-stage preparation |
| 06/12/1997 | CA2192281A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/11/1997 | EP0778277A1 Substituted heterocyclic derivatives as CRF antagonists |
| 06/11/1997 | EP0778271A2 Aminoalkyl-substituted benzo-heterocyclic compounds |
| 06/11/1997 | EP0778264A1 Tertiary amines having antimycotic and cholesterol lowering activity |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |
| 06/11/1997 | EP0777672A1 Amino acid chelates having improved palatability |
| 06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
| 06/11/1997 | EP0777489A1 Low molecular yeast active substance extract and process for preparing the same |